aTyr Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of aTyr Pharma generated cash of -$33,220,999, which is more than the previous year. Cash used in financing activities reached the amount of $66,230,000 last year. Net change in cash is therefore $12,882,000.
Cash Flow
| 2015 | -36.79M | -71.99M | 147.91M |
|---|---|---|---|
| 2017 | -42.36M | -27.63M | 52.70M |
| 2019 | -20.01M | 4.92M | 1.33M |
| 2022 | -41.88M | 47.24M | 5.45M |
| 2023 | -33.22M | -20.12M | 66.23M |
ATYR Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 13.14M | 2.33M | 22.96M | 38.38M | 13.89M |
Operating activities | |||||
Net income | -50.38M | -45.33M | -23.60M | -48.20M | -47.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.74M | 1.69M | 1.36M | 713K | 869K |
Stock-based compensation expense | 2.6M | 2.15M | 1.78M | 0 | 4.85M |
| Deferred income tax benefit | 2.6M | 2.15M | 1.78M | 0 | 4.85M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 9.05M | -11.92M | 58K | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 3.26M | 6.74M | 162K | -2.49M | 0 |
Cash generated by operating activities | -33.22M | -41.88M | -20.01M | -42.36M | -36.79M |
Investing activities | |||||
Purchases Of Investments | -106.97M | -42.11M | -40.64M | -77.67M | -109.44M |
Investments In Property Plant And Equipment | -4.21M | -1.64M | -79K | -1.31M | -664K |
Acquisitions Net | 0 | 179K | 51K | 0 | 0 |
Cash generated by investing activities | -20.12M | 47.24M | 4.92M | -27.63M | -71.99M |
Financing activities | |||||
Common Stock Issued | 66.51M | 5.47M | 9.32M | 42.47M | 76.90M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -394K | -66K | -8M | 9.86M | -5.23M |
Cash used in financing activities | 66.23M | 5.45M | 1.33M | 52.70M | 147.91M |
Net Change In Cash | 12.88M | 7.64M | -13.75M | -17.29M | 39.12M |
Cash at end of period | 26.02M | 9.98M | 9.21M | 21.09M | 53.02M |